scholarly journals Imaging topography and morphometry of persistent left superior caval vein and its variations, detected on cardiac implantable electronic device implantation

2017 ◽  
Vol 76 (1) ◽  
pp. 58-65 ◽  
Author(s):  
R. Steckiewicz ◽  
E. B. Świętoń ◽  
J. Czerniawska ◽  
P. Scisło ◽  
P. Stolarz
Keyword(s):  
Electronic Device ◽  
Cardiac Implantable Electronic Device ◽  
Caval Vein ◽  
Superior Caval Vein ◽  
Device Implantation

scholarly journals Postoperative Pain Control Following Cardiac Implantable Electronic Device Implantation

2021 ◽  
Author(s):  
Peter Magnusson ◽  
Jo Ann LeQuang ◽  
Joseph V. Pergolizzi
Keyword(s):  
Postoperative Pain ◽  
Pain Control ◽  
Electronic Device ◽  
Perioperative Period ◽  
Cardiac Implantable Electronic Device ◽  
Opioid Use ◽  
Acute Postoperative Pain ◽  
Device Implantation ◽  
Analgesic Regimen ◽  
Short Course

Postoperative pain following cardiac implantable electronic device (CIED) surgery may not always be adequately treated. The postoperative pain trajectory occurs over several days following the procedure with tenderness and limited arm range of motion lasting for weeks after surgery. Pain control typically commences in the perioperative period while the patient is in the hospital and may continue after discharge; outpatients may be given a prescription and advice for their analgesic regimen. It is not unusual for CIED patients to be discharged a few hours after implantation. While opioids are known as an effective analgesic to manage acute postoperative pain, growing scrutiny on opioid use as well as their side effects and potential risks have limited their use. Opioids may be considered for appropriate patients for a short course of treatment of acute postoperative pain, but other analgesics may likewise be considered.

scholarly journals Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study

EP Europace ◽  
2017 ◽  
Vol 19 (6) ◽  
pp. 1007-1014 ◽  
Author(s):  
Cengiz Özcan ◽  
Jakob Raunsø ◽  
Morten Lamberts ◽  
Lars Køber ◽  
Tommi Bo Lindhardt ◽  
...  
Keyword(s):  
Cohort Study ◽  
Infective Endocarditis ◽  
Electronic Device ◽  
Cardiac Implantable Electronic Device ◽  
Risk Of Death ◽  
Device Implantation

scholarly journals Subclavian and Axillary Vein Access Versus Cephalic Vein Cutdown for Cardiac Implantable Electronic Device Implantation

2020 ◽  
Vol 6 (6) ◽  
pp. 661-671 ◽  
Author(s):  
Varunsiri Atti ◽  
Mohit K. Turagam ◽  
Jalaj Garg ◽  
Scott Koerber ◽  
Aakash Angirekula ◽  
...  
Keyword(s):  
Electronic Device ◽  
Cephalic Vein ◽  
Axillary Vein ◽  
Cardiac Implantable Electronic Device ◽  
Device Implantation ◽  
Vein Access

Percutaneous recanalization of superior vena cava occlusions for cardiac implantable electronic device implantation: Tools and techniques

Heart Rhythm ◽  
2020 ◽  
Vol 17 (11) ◽  
pp. 2010-2015 ◽  
Author(s):  
Naga Venkata K. Pothineni ◽  
C. Anwar A. Chahal ◽  
David S. Frankel ◽  
Fermin C. Garcia ◽  
Jay Giri ◽  
...  
Keyword(s):  
Superior Vena Cava ◽  
Electronic Device ◽  
Superior Vena ◽  
Vena Cava ◽  
Cardiac Implantable Electronic Device ◽  
Device Implantation ◽  
Percutaneous Recanalization ◽  
Tools And Techniques

Periprocedural management of patients on anticoagulants and antiplatelet agents undergoing cardiac implantable electronic device implantation

2018 ◽  
Vol 1 (46) ◽  
pp. 17-23
Author(s):  
Paweł Basiukiewicz ◽  
Janusz Bednarski ◽  
Łukasz Pastwa ◽  
Anna Chudoba
Keyword(s):  
Anticoagulant Therapy ◽  
Perioperative Management ◽  
Electronic Device ◽  
Antiplatelet Agents ◽  
Cardiac Implantable Electronic Device ◽  
Bridging Therapy ◽  
Periprocedural Management ◽  
Device Implantation ◽  
Anticoagulant Agents

Almost half of patients who underwent CIED implantation receive antiplatelet or anticoagulant agents. Despite the number of trials, also randomized perioperative management with antiplatelet/anticoagulant therapy differs between centers. Some of physicians withdraw antiplatelet or anticoagulant therapy because of risk of pocket haematoma that could lead to reintervention, while some of them continue antiplatelet/anticoagulant therapy without concerns or put patient on the bridging therapy with LMWH. This article is an attempt to summarize reports and recommendations concerning problem of antiplatelet and antitrombotic therapy in periprocedural CIED period.

Sign in / Sign up

Export Citation Format

Share Document